ArticleThe FEBS journal2023

CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.

Christian Söhngen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.